Ionis Pharmaceuticals Inc (IONS)
41.97
-1.12
(-2.60%)
USD |
NASDAQ |
May 03, 16:00
41.97
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals Cash and Short Term Investments (Quarterly): 2.331B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.331B |
| September 30, 2023 | 2.236B |
| June 30, 2023 | 2.385B |
| March 31, 2023 | 2.347B |
| December 31, 2022 | 1.987B |
| September 30, 2022 | 1.982B |
| June 30, 2022 | 2.022B |
| March 31, 2022 | 2.052B |
| December 31, 2021 | 2.115B |
| September 30, 2021 | 1.987B |
| June 30, 2021 | 2.059B |
| March 31, 2021 | 1.820B |
| December 31, 2020 | 1.892B |
| September 30, 2020 | 2.329B |
| June 30, 2020 | 2.349B |
| March 31, 2020 | 2.384B |
| December 31, 2019 | 2.500B |
| September 30, 2019 | 2.221B |
| June 30, 2019 | 2.262B |
| March 31, 2019 | 2.254B |
| December 31, 2018 | 2.084B |
| September 30, 2018 | 1.959B |
| June 30, 2018 | 1.980B |
| March 31, 2018 | 1.035B |
| December 31, 2017 | 1.023B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.011B |
| June 30, 2017 | 855.71M |
| March 31, 2017 | 860.28M |
| December 31, 2016 | 665.22M |
| September 30, 2016 | 697.23M |
| June 30, 2016 | 672.31M |
| March 31, 2016 | 723.51M |
| December 31, 2015 | 803.98M |
| September 30, 2015 | 830.79M |
| June 30, 2015 | 815.54M |
| March 31, 2015 | 788.50M |
| December 31, 2014 | 810.71M |
| September 30, 2014 | 639.41M |
| June 30, 2014 | 647.51M |
| March 31, 2014 | 694.88M |
| December 31, 2013 | 708.86M |
| September 30, 2013 | 735.90M |
| June 30, 2013 | 652.94M |
| March 31, 2013 | 416.77M |
| December 31, 2012 | 408.07M |
| September 30, 2012 | 343.57M |
| June 30, 2012 | 336.03M |
| March 31, 2012 | 333.94M |
| December 31, 2011 | 343.66M |
| September 30, 2011 | 364.76M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.820B
Minimum
Mar 2021
2.500B
Maximum
Dec 2019
2.172B
Average
2.221B
Median
Sep 2019
Cash and Short Term Investments (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 634.13M |
| Viking Therapeutics Inc | 962.98M |
| Alnylam Pharmaceuticals Inc | 2.371B |
| Akero Therapeutics Inc | 550.01M |
| 89bio Inc | 578.87M |